Market Expansion Opportunities Sonoma Pharmaceuticals is actively expanding its geographic reach, including launching products in major UK pharmacy chains and increasing distribution in Canada and the US through strategic partnerships. This indicates strong potential for sales growth in international markets and collaboration with distributors to penetrate new regions.

Innovative Product Pipeline The company's recent launches such as the Lumacyn Clarifying Mist and expanded eye care products showcase its focus on innovative, OTC and prescription dermatological solutions. There are opportunities to introduce these new products into healthcare providers, clinics, and commercial pharmacies seeking advanced skincare and wound care options.

Strategic Partnerships Partnerships with Medline Industries and EMC Pharma have enhanced Sonoma's distribution channels and product offerings. These collaborations suggest potential for joint marketing efforts and co-selling opportunities, especially in expanding wound care and eye care product lines to medical facilities and retail channels.

Participation in Industry Events Active participation in major dermatology and healthcare conferences like MEDICA and the American Academy of Dermatology presents opportunities to connect with key decision-makers, showcase product innovations, andgenerate leads from dermatologists, clinics, and healthcare providers interested in advanced tissue care solutions.

Growth in Dermatological Focus With a focus on dermatology and advanced tissue care solutions, Sonoma is positioned to attract medical professionals and clinics specializing in skin and wound care. Tailored outreach to dermatologists, wound care specialists, and hospitals can unlock additional B2B sales and expand market share for its innovative hypochlorous acid-based products.